Fresenius SE & Co KGaA (FRE)

Industry Medical Care Facilities


This stock can be held in an Investment ISA and an Investment Account
Sell

Buy

arrow-up€ (+%)

Prices updated at 15 May 2025, 17:07
| Prices minimum 15 mins delay
|
Prices in EUR

Fresenius SE & Co KGaA is a holding company engaged in healthcare business. It provides dialysis machines, and manufactures equipment for Medical Care through its subsidiaries. The company also manufactures IV drugs, clinical nutrition, and infusion.
Sector
Healthcare
Industry
Medical Care Facilities
Chairman
Ms. Grit Genster
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
175,202
Head office
Else-Kroener-Strasse 1
Bad Homburg
Germany
61352
mobile
+49 61726080
letter
markus.georgi@fresenius.com

Key personnel

Salary
Mr. Michael Diekmann
Deputy Chairman of Supervisory Board
-
Mr. Wolfgang Kirsch
Chairman of Supervisory Board
-
Mr. Konrad Kolbl
Member of Supervisory Board
-
Professor Dr. Michael Albrecht, Dr. Med.
Member of Supervisory Board
-
Professor Dr. Iris Low-Friedrich, Dr. Med.
Member of Supervisory Board
-
Mr. Bernd Behlert
Member of Supervisory Board
-
Ms. Grit Genster
Deputy Chairman of Supervisory Board
-
Ms. Frauke Lehmann
Member of Supervisory Board
-
Mr. Oscar Romero de Paco
Member of Supervisory Board
-
Ms. Susanne Zeidler
Member of Supervisory Board
-
Dr. Christoph Zindel, M.D.
Member of Supervisory Board
-
Mr. Holger Michel
Member of Supervisory Board
-

Top 5 shareholders

No. of shares
Fidelity Management & Research Company LLC13,583,785
Harris Associates L.P.12,793,162
Vanguard Group Inc11,848,838
BlackRock Fund Advisors8,489,499
Deutsche Asset Management Investment GmbH8,436,707

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.